Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Reginald E. Greene, R H Rubin(Massachusetts General Hospital), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), J W Oestmann(Charité - Universitätsmedizin Berlin), H. T. Schlamm(Pfizer (United States)), Raoul Herbrecht(Institut de Cancérologie Strasbourg), Paul Stark, Olivier Lortholary(Hôpital Necker-Enfants Malades), John E. Bennett(National Institute of Allergy and Infectious Diseases), Peter F. Troke, David W. Denning(Manchester Academic Health Science Centre), Patricia Ribaud(Hôpital Saint-Louis), John R. Wingard(University of Florida Health), B.E. de Pauw(Radboud University Nijmegen), Christine M. Durand(University of Maryland, Baltimore)
Cited by 585
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
|Journal of Fungi|2017|2.9k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k